Notes - Segment Information

ONO PHARMACEUTICAL CO., LTD. - Filing #7242262

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
Notes - Segment information
Segment information
Revenue
Revenue
486,871,000,000 JPY
502,672,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
125,000,000 JPY
1,000,000 JPY
Profit (loss) before tax
59,328,000,000 JPY
163,734,000,000 JPY
Assets
1,064,046,000,000 JPY
913,668,000,000 JPY
Investments accounted for using equity method
JPY
115,000,000 JPY
Impairment losses
1,981,000,000 JPY
51,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.